跳至主要内容
临床试验/NCT05294978
NCT05294978招募中不适用

Qualification for Cone-Optogenetics (EyeConic)

Institute of Molecular and Clinical Ophthalmology Basel9 个研究点 分布在 7 个国家目标入组 1,000 人开始时间: 2021年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000
试验地点
9
主要终点
OCT - Central retinal volume

研究概览

简要总结

This study aims to prepare for the first-in-human clinical trial of cone optogenetics vision restoration. As a first step, this worldwide multicenter ocular imaging study (EyeConic Study) is performed to identify eligible patients.

详细描述

In a subset of patients with inherited retinal dystrophies (IRDs), cones lose their light-sensitive outer segments but remain alive in a dormant stage. This creates an opportunity to resensitize them through targeted optogenetic tools. However, the true proportion of low vision patients harboring dormant, non-functional cones, is currently unknown. The worldwide multicenter retrospective study (EyeConic) aims to estimate the proportion of low vision patients with remaining cone cell bodies for the first time.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

OCT - Central retinal volume

时间窗: Baseline (about 10 minutes)

Number of participants with preserved central retinal volume

次要结局

未报告次要终点

研究者

发起方
Institute of Molecular and Clinical Ophthalmology Basel
申办方类型
Other
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验